Caredx Inc Stock
€32.00
Your prediction
Caredx Inc Stock
CareDx is a publicly traded biotechnology company that specializes in providing innovative transplant solutions for patients suffering from various diseases. The company has developed a range of diagnostic solutions that help doctors monitor the health of organ transplant recipients, including tests that can detect early signs of organ rejection. CareDx has a strong track record of developing cutting-edge medical technologies and working with leading healthcare providers to improve patient outcomes. As a publicly-listed company, CareDx has a diverse shareholder base and is subject to the scrutiny of regulatory bodies, providing transparency and accountability to investors.
Pros and Cons of Caredx Inc in the next few years
Pros
Cons
Performance of Caredx Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Caredx Inc | -2.440% | -4.762% | 30.081% | 192.772% | 96.078% | 213.725% | -54.286% |
| Evolus Inc | -2.840% | 7.594% | -16.281% | -34.825% | -4.330% | -23.883% | -40.750% |
| Rhythm Pharmaceuticals | -1.600% | -3.261% | -7.772% | 22.759% | -4.813% | 470.513% | 463.291% |
| Genfit S.A. | 0.150% | 0.296% | 33.531% | 277.790% | 151.673% | 287.966% | 320.236% |
News
CareDx's CEO Sells 17K Shares
CareDx (NASDAQ:CDNA), a leader in transplant diagnostics, saw a key insider reduce his direct holdings amid a series of scheduled transactions.
John Hanna, President and CEO of CareDx, disclosed the
CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans
Key Points
- Interested in CareDx, Inc.? Here are five stocks we like better.
- CareDx is pivoting deeper into precision diagnostics by divesting its lab products unit and using the proceeds to
CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies
Key Points
- Interested in CareDx, Inc.? Here are five stocks we like better.
- CareDx posted strong Q1 results, with revenue up 39% year over year and Testing Services volume up 17%. The company